- In August 2024, DePuy Synthes, part of Johnson & Johnson MedTech, launched the MatrixSTERNUM Fixation System. This system is designed to stabilize the chest wall following open-heart and chest surgeries, offering enhanced locking strength and expedited chest fixation
- In May 2024, Abbott Laboratories introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This device features an upgraded stent design and an innovative delivery mechanism, aimed at assisting healthcare professionals in addressing complex cardiac cases
- In October 2023, SS Innovations International, Inc. launched an inventive robotic cardiac surgery program in India. This program utilizes the company's flagship SSi Mantra surgical robotic system, aiming to lower the cost of robotic surgery and increase its accessibility
- In October 2022, The U.S. FDA has given Medtronic plc permission for extended labeling of a cardiac lead that uses the heart's natural electrical circuitry to deliver essential treatment while avoiding problems such as cardiomyopathy frequently associated with conventional pacing techniques
- In October 2022, The HELIOSTAR Balloon Ablation Catheter was introduced in Europe by Biosense Webster, Inc., a Johnson & Johnson MedTech subsidiary. When used with a suitable multi-channel RF generator, the HELIOSTAR Balloon Ablation Catheter is approved for cardiac ablation and catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria
